Morquio syndrome is a very rare inherited disease. It is called mucopolysaccharidosis because the body cannot break down mucopolysaccharides which make up mucous. It has very serious effects, but can be helped by a synthetic version of the enzyme which is not working.
References[change | change source]
- "MPS IV (Morquio syndrome)". MPSSociety.org. National MPS Society. Archived from the original on 21 August 2017. Retrieved 14 January 2015. CS1 maint: discouraged parameter (link)
- US Food and Drug Administration (14 February 2014). "FDA approves Vimizim to treat rare congenital enzyme disorder". Press release. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm386008.htm. Retrieved 14 January 2015.